Neuronatin: A New Inflammation Gene Expressed on the Aortic Endothelium of Diabetic Mice by Mzhavia, Nino et al.
Neuronatin: A New Inﬂammation Gene Expressed on the
Aortic Endothelium of Diabetic Mice
Nino Mzhavia,
1 Shuiqing Yu,
1 Shota Ikeda,
2 Tehua T. Chu,
3 Ira Goldberg,
1,2 and Hayes M. Dansky
1
OBJECTIVE—Identiﬁcation of arterial genes and pathways
altered in obesity and diabetes.
RESEARCH DESIGN AND METHODS—Aortic gene expres-
sion proﬁles of obese and diabetic db/db, high-fat diet–fed
C57BL/6J, and control mice were obtained using mouse Af-
fymetrix arrays. Neuronatin (Nnat) was selected for further
analysis. To determine the function of Nnat, a recombinant
adenovirus (Ad-Nnat) was used to overexpress the Nnat gene in
primary endothelial cells and in the mouse aorta in vivo.
RESULTS—Nnat, a gene of unknown vascular function, was
upregulated in the aortas of db/db and high-fat diet–fed mice.
Nnat gene expression was increased in db/db mouse aorta
endothelial cells. Nnat protein was localized to aortic endothe-
lium and was selectively increased in the endothelium of db/db
mice. Infection of primary human aortic endothelial cells
(HAECs) with Ad-Nnat increased expression of a panel of
nuclear factor-B (NF-B)-regulated genes, including inﬂamma-
tory cytokines, chemokines, and cell adhesion molecules. Infec-
tion of mouse carotid arteries in vivo with the Ad-Nnat increased
expression of vascular cell adhesion molecule 1 protein. Nnat
activation of NF-B and inﬂammatory gene expression in HAECs
was mediated through pathways distinct from tumor necrosis
factor-. Nnat expression stimulated p38, Jun NH2-terminal
kinase, extracellular signal–related kinase, and AKT kinase
phosphorylation. Phosphatidylinositol 3-kinase and p38 inhib-
itors prevented Nnat-mediated activation of NF-B–induced
gene expression.
CONCLUSIONS—Nnat expression is increased in endothelial
cells of obese and diabetic mouse blood vessels. The effects of
Nnat on inﬂammatory pathways in vitro and in vivo suggest a
pathophysiological role of this new gene in diabetic vascular
diseases. Diabetes 57:2774–2783, 2008
E
pidemiological data has shown a strong associ-
ation between diabetes and coronary heart dis-
ease (1,2). Although insulin-mediated improved
glucose control reduced cardiovascular events
in subjects with type 1 diabetes (3), less deﬁnitive infor-
mation is available relating diabetes control and athero-
sclerosis prevention in type 2 diabetes. Recent ﬁndings
suggest that hyperglycemia is associated with increased
arterial wall inﬂammation (4) and increased expression of
vascular inﬂammatory molecules, such as vascular cell
adhesion molecule-1 (VCAM-1), intercellular adhesion
molecule-1 (ICAM-1), and E-Selectin (SELE) (5,6); nuclear
factor-B (NF-B) activation (7,8); and inﬂammatory cy-
tokine production. Fundamental understanding of the ef-
fects of diabetes on arterial genes and pathways may
contribute to the discovery of new strategies for the
treatment of diabetic vascular diseases beyond blood
glucose control.
Animal models of diabetes have been used to study the
effects of hyperglycemia and insulin resistance at different
stages of disease progression (9,10). We (11,12) and others
(13,14) have demonstrated that mouse models of type 2
diabetes such as leptin receptor mutant db/db and diet-
induced obesity mice have impaired vascular function.
Kim et al. (15) demonstrated that high-fat diet feeding
increases expression of markers of vascular inﬂammation
in mouse thoracic aortas. Also, apolipoprotein E knockout
db/db mice have increased VCAM-1 expression in aorta
(16) and greater aortic sinus atherosclerosis (16,17). How-
ever, not all investigators have observed changes in ex-
pression of adhesion molecules in db/db mouse aortas
(18).
A number of studies have focused on the effects of
diabetes on vascular cells. Endothelial cells isolated from
db/db aortas have increased inﬂammatory cytokine and
chemokine expression and more monocyte adhesion (19–
21). The reasons for the altered biology of these cells is
thought by many to be due to hyperglycemia; increased
glucose concentrations induce interleukin (IL)-6, IL-8, and
monocyte chemotactic protein-1 (MCP-1) secretion and
adhesion molecule expression in endothelial cells. IL-6/IL-
6R complex can induce an inﬂammatory phenotype in
endothelial cells, promoting SELE, ICAM-1, and VCAM-1
expression and monocyte adhesion (21,22).
In the current study, we performed gene expression
proﬁling of aortas from two mouse models of type 2
diabetes to identify new genes and pathways that contrib-
ute to diabetic vascular diseases. We found that neurona-
tin (Nnat), a gene with unknown vascular function, was
upregulated in the aortas of both db/db and high-fat
diet–fed mice. Immunohistochemical studies localized
Nnat to the vascular endothelium. To gain insight into the
function of this molecule, the effects of adenovirus-
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(HAECs) and mouse arteries were studied.
RESEARCH DESIGN AND METHODS
All procedures were approved by the institutional animal care and use
committee. Male C57BL/6J (strain 000664), db/db (Lepr
db/db strain 000642), and
heterozygous littermate (db/) mice were purchased from The Jackson
Laboratories (Bar Harbor, ME). Mice were maintained in a temperature-
controlled barrier facility with a 12-h light/dark cycle and were given free
access to food and water. db/db mice were killed at 16–20 weeks of age. To
induce obesity and diabetes, C57BL/6J mice were fed a high-fat TD03584 diet
(Harlan Tekland, Indianapolis, IN) for 16–20 weeks starting at the age of 10
weeks. Control mice were fed regular chow. The high-fat diet contained 35%
fat and 37% carbohydrate.
Mouse aorta endothelial cell isolation. Endothelial cells were isolated by
sorting with magnetic beads using anti–platelet-endothelial cell adhesion
molecule-1 (CD31) biotin-conjugated antibody (Millipore). In brief, mice were
anesthetized and perfused with 1,000 units/ml heparin in PBS. Aortas were
isolated, stripped of perivascular fat, and incubated in RPMI containing 2
mg/ml collagenase 2 and 2 units/ml dispase for 30 min at 37°C. Cells were
collected by centrifugation at 400g at 4°C and washed twice with MACS
(magnetic cell sorting) buffer (Hanks’ balanced salt solution [Ca/Mg free], 2
mmol/l EDTA, and 0.5% BSA). The cells suspension was run through 70- and
40-m cell strainers. Cells were incubated with CD31 antibody for 15 min,
washed and incubated with streptavidin SA-Microbeads (Miltenyi Biotec) for
another 15 min, washed again, and applied to an equilibrated column. After
several washes, the column was removed from the magnetic holder, and cells
were eluted with MACS buffer. Endothelial cells were collected by centrifu-
gation at 400g and processed for RNA isolation.
Expression of adenovirus-encoded Nnat in endothelial cells. HAECs
were obtained from Cambrex Life Science. Cells were grown in endothelial
cell growth medium EGM-2 to conﬂuency and were infected with Ad-Nnat,
Ad–green ﬂuorescent protein (Ad-GFP), or Ad-Empty at multiplicity of
infection (MOI) 10 unless indicated otherwise. Gene expression was assessed
by real-time PCR, and proteins were analyzed by Western blot 48 h after
infection. For treatment with tumor necrosis factor- (TNF-), TNF-–
blocking antibody, or kinase inhibitors, cells were treated 24 h after infection
for another 24 h. Kinase inhibitors used in the study are 20 mol/l U0126, 20
mol/l SP600125, 5 mol/l IKK-VII, 10 mol/l SB202190, 50 mol/l LY294002,
and 0.2 mol/l wortmannin.
Real-time PCR. Primers for conventional real-time PCR were designed
(supplementary Table S1, available in an online appendix at http://dx.doi.org/
10.2337/db07-1746) or obtained from SuperArray Bioscience (Frederick, MD).
Expression levels for individual genes were normalized to -actin in mouse
tissue and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in HAECs.
For RT
2 Proﬁler PCR array, 1 g RNA pool from HAECs infected with
adenovirus was used for cDNA synthesis and analysis by human endothelial
cell biology RT
2 Proﬁler PCR array according to manufacturer’s instructions
(SuperArray Bioscience).
Western blot analysis. Cell homogenates were made in buffer (10 mmol/l
Tris-Cl, pH 7.4; 5 mmol/l EDTA; 150 mmol/l NaCl; 10% glycerol; and 1% Triton
X-100) containing a protease inhibitor cocktail for mammalian tissues (Sigma-
Aldrich, St. Louis, MO) and phosphatase inhibitors (Roche Applied Science,
Indianapolis, IN). Antibodies used are as follows: inhibitor of B( I B)-,
ICAM-1, and VCAM-1 (Santa Cruz Biotechnology, Santa Cruz, CA); stress-
activated protein kinase (SAPK)/Jun NH2-terminal kinase (JNK), p38, extra-
cellular signal–related kinase 1/2 (ERK1/2), NF-B activating kinase (NAK),
p65, and Akt (Cell Signaling Technology); SELE (BioVision); -actin (ABcam);
and TNF- (BioLegend).
Gene transfer into mouse carotid artery. According to the method of
Vassalli et al. (23), in vivo gene transfer was conducted using Ad-GFP or
Ad-Nnat virus. Two days after the adenovirus infection, carotid arteries were
isolated and ﬁxed in 4% paraformaldehyde and processed for immunohisto-
chemical analysis as described above. Intensity of staining was determined in
sections from 4 to 7 Ad-Nnat– and Ad-GFP–infected mouse carotid arteries
using Image Pro Plus software.
RESULTS
Gene expression proﬁling of aortas from diabetic
mice. Gene expression proﬁling was performed to identify
differentially expressed genes in the aortas of diabetic
mice. Metabolic data for db/db and high-fat diet–fed
C67BL6/J mice are shown in Table 1. To create mice with
comparable weights and insulin levels, we used 16- to
18-week-old db/db mice and 28-week-old high-fat diet–
fed animals. Glucose levels were higher in db/db compared
with high-fat diet–fed mice, but body weight (47 and 49 g,
respectively) and insulin (912 and 775 pmol/l, respectively)
were comparable between the two groups. As expected,
cholesterol levels were greater in db/db than db/ mice.
Expression of 43 genes increased and expression of 3
genes decreased at least twofold in aortas of db/db mice
when compared with nondiabetic db/ controls (supple-
mentary Table S2). In high-fat diet–fed mice, 85 aortic
genes were upregulated, and 42 aortic genes were down-
regulated (supplementary Table S3). Analysis of gene
expression across the two diabetic models revealed 10
genes that were differentially expressed in the aortas of
diabetic mice (Table 2), but there were only 4 genes in
which the direction of change was similar. These genes
were Nnat, leptin, natriuretic peptide receptor 3, and
lectin galactose binding, soluble 3. Among these common
TABLE 1
Metabolic data for db/db and diet-induced obesity and diabetes models
Mice Weight (g)
Glucose
(mmol/l)
Insulin
(pmol/l)
TC
(mg/dl)
TG
(mg/dl)
Chow 29.3  0.57 7.4  0.11 86  5.2 132  6.1 17  1.9
High fat 49.3  0.52* 12.7  0.83* 775  132.5* 149  8.9 16  2.2
db/ 28.2  0.29 6.4  0.22 121  15.5 132  83 2  4
db/db 47.3  0.54* 21.2  1.02* 912  141.1* 194  7* 43  7
Data are means  SE. Blood from db/db mice was collected at 14–19 weeks of age (n  18). C57BL6/J mice with diet-induced obesity and
diabetes were studied after 6–20 weeks on mice on high-fat diet (n  9). Triglyceride (TG) and total cholesterol (TC) measurements done
were done at 9 weeks. *P 	 0.0001 data comparison were between db/db vs. db/ and high-fat vs. chow-fat mice.
TABLE 2
Genes changed in two models of obesity and type 2 diabetes
Gene name
Gene
symbol
Fold change
db/db DIO
Neuronatin Nnat 9.4 2.5
Leptin Lep 4.6 3.7
Natriuretic peptide receptor 3 Npr3 2.3 4.9
Lectin, galactose binding, soluble 3 Lgals3 2.2 3.5
Transthyretin Ttr 4.0 0.4
Apolipoprotein A-II Apoa2 3.8 0.4
Fatty acid binding protein 1 Fabp1 3.4 0.4
Cytochrome P450, family 3,
subfamily a, 11 Cyp3a11 3.1 0.4
Group-speciﬁc component Gc 3.1 0.4
Serine (or cysteine) peptidase
inhibitor, clade A, 1c Serpina1c 2.8 0.2
Fold change represent values obtained after data analysis with
Wilcoxon test. DIO, diet-induced obesity and diabetes. See supple-
mental RESEARCH DESIGN AND METHODS in the online appendix for the
details of the data analysis.
N. MZHAVIA AND ASSOCIATES
DIABETES, VOL. 57, OCTOBER 2008 2775genes, the most strongly upregulated gene was Nnat. Nnat
mRNA was upregulated 9-fold in the db/db and 2.5-fold in
the high-fat diet–induced model. Therefore, we elected to
focus our subsequent studies on identifying a role for Nnat
in the aorta of diabetic mice.
Nnat was upregulated in the aortic endothelium of
diabetic mice. Real-time PCR was performed to quantify
Nnat expression in the mouse aorta. Nnat mRNA expres-
sion was higher in the aorta of db/db and high-fat diet–fed
diabetic mice when compared with littermate controls
(Fig. 1A). Immunohistochemical staining of mouse aorta
localized the Nnat protein in endothelial cells (Fig. 1B).
Compared with control mice, the endothelium of db/db
mice had more intense staining (Fig. 1B and C). The
difference in Nnat staining was less prominent in the
aortas from high-fat diet–fed compared with chow diet–
fed control mice, and the difference was not statistically
signiﬁcant (Fig. 1B and C). Analysis of aorta sections
stained with Nnat antibody revealed that not only endo-
thelial cells but also perivascular fat stains positive for
Nnat (supplementary Fig. S2).
Nnat gene expression was increased in endothelial
cells of db/db mouse aorta. To reassure that the in-
crease in Nnat is due to endothelial cell expression, we
isolated mouse aorta endothelial cells using magnetic bead
cell sorting with CD31 antibody. Endothelial cell isolation
was conﬁrmed by assessing endothelial-speciﬁc (endothe-
lial nitric oxide [NO] synthase, vascular endothelial–cad-
herin), macrophage-speciﬁc (F4/80), and ﬁbroblast- and
smooth muscle cell–speciﬁc (Col3a) gene expression in
CD31-positive and -negative cells (supplementary Fig.
S2A). -Nnat expression was increased approximately
fourfold in the db/db endothelial cell preparations (Fig.
1D), whereas total nnat expression was increased only
approximately twofold (Fig. 1E); the conﬁrmation that this
analysis detected both - and -isoforms of Nnat in mouse
endothelial cells is shown in Fig. 1F. Because total Nnat
expression changed less than -Nnat, it is likely that
-Nnat expression did not change or decreased in these
mice.
Nnat expression in cultured primary aortic endothe-
lial cells. The effects of Nnat expression were investi-
gated in cultured HAECs. At baseline conditions, real-time
PCR and Western blotting studies revealed low levels of
transcript and no detectable protein in these cells (data
not shown). To determine whether metabolic stimuli
would induce Nnat expression, HAECs were cultured for
1–4 days in the presence of 25 mmol/l glucose, 100 ng/ml
leptin, or 10 g/ml insulin. These manipulations did not
increase Nnat gene expression (data not shown). Because
Nnat is an imprinted gene, it was possible that Nnat
expression was repressed by DNA methylation. Treatment
of HAECs with 5-Aza-2
-deoxycytidine (ADC), an inhibitor
of DNA methyl transferase, increased Nnat mRNA levels
(supplementary Figure S4A). Treatment of the cells with
high-glucose insulin and leptin after induction of Nnat
expression with ADC did not result in the further increase
of Nnat (supplementary Figure S4B).
HAECs were infected with an Ad-Nnat to determine the
downstream effects of Nnat expression. Western blotting
revealed high levels of the Nnat protein in infected cells
(Fig. 2A and C; see below). Because the function of Nnat
in endothelium was unknown, we compared gene expres-
sion in endothelial cells infected with Ad-Nnat to that of an
empty adenovirus control (Ad-Empty) using an endothelial
cell biology RT
2 Proﬁler PCR array. Of 84 endothelial-
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FIG. 1. Nnat expression in mouse aorta. A: Real-time PCR measurement of
-Nnat mRNA in the aortas of diabetic mice (C57BLKS/J db/db and high-fat
diet–fed C57BL/6J) and their respective controls (C57BLKS/J db/, and
chow diet–fed C57BL/6J) (n4–6). Nnat expression levels were normalized
to -actin. B: Representative immunohistochemical staining of db/db versus
db/ (top) and high-fat diet– versus chow diet–fed (bottom) mouse aorta
parafﬁn sections with Nnat antibody. Magniﬁcation 100. C: Comparison of
integrated intensities of Nnat staining determined using Image-Pro Plus
software, n  4. D and E: Real-time PCR data for -Nnat (D) and total Nnat
(E) expression in endothelial cells isolated form db/db or control db/
mouse aortas, n  5–6. F: Gel electrophoresis of PCR fragments ampliﬁed
from endothelial cells RNA using primers for both  and  Nnat isoforms.
**P < 0.01, *P < 0.05. (Please see http://dx.doi.org/10.2337/db07-1746 for a
high-quality digital representation of this image.)
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infected cells. Twenty-one genes were increased, and six
were decreased (supplementary Table S4). Among the
increased genes, four major groups were apparent: 1)
cytokines (IL-1, IL-6, IL-7, IL-11, and TNF-) and chemo-
kines (CX3CL1 and CCL2); 2) adhesion molecules
(ICAM-1, VCAM-1, and SELE); 3) growth factors (vascular
endothelial growth factor, endothelial cell growth factor-1,
and placental growth factor); and 4) extracellular matrix
proteases/inhibitors (matrix metallopeptidase-1; serpin
peptidase inhibitor, clade E, member-1; and plasminogen
activator urokinase). The changes in TNF-, IL-1, IL-6,
MCP-1 (CCL2), ICAM-1, VCAM-1, and SELE expression in
Ad-Nnat–infected cells were veriﬁed by real-time PCR
(Table 3). These results suggest that Nnat expression
activates endothelial cells.
Nnat expression activates NF-B in endothelial cells.
Many genes induced by Nnat expression in HAECs are
regulated by NF-B. To study this, HAECs were infected
with increasing numbers of Ad-Nnat particles per cell from
MOI 3 to 20. At MOI 10–20, Nnat protein expression
paralleled with IB- decrease and with ICAM-1 and
VCAM-1 protein (Fig. 2A) and IL-6 mRNA increase (Fig.
2B). Time course analysis of Nnat expression also demon-
strated that accumulation of Nnat protein was accompa-
nied by an increase of immunoreactive NAK, a decrease in
IB-, and an increase in phosphorylation of the p65
subunit of the NF-B transcription complex (Fig. 2C).
Increases in IL-6 accompanied the time-dependent in-
crease in Nnat expression and activation of NF-B (Fig.
2D). ICAM-1 and TNF- mRNA expression also increased
with time, and IL-1 and SELE were increased only after
48 h (data not shown).
Nnat- versus TNF-–induced activation of NF-B
transcription factor. Additional experiments were per-
formed to identify the signal transduction pathways by
which Nnat activated NF-B in endothelial cells. Because
Nnat induced TNF- mRNA expression (Table 3), we
A B
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FIG. 2. Nnat expression in HAECs activates NF-B–dependent gene expression in time- and concentration-dependent manner. A: Western blots
of Nnat, VCAM-1, ICAM-1, and IB- protein from endothelial cells infected with Ad-Empty, Ad-GFP, and increasing number of Ad-Nnat
adenovirus per cell (MOI). B: Real-time PCR measurement of IL-6 mRNA expression in endothelial cells infected with Ad-Empty, Ad-GFP, or
Ad-Nnat at different MOI. (n  3). C: Endothelial cells were collected at various times after infection with Ad-Nnat and Western blots were
probed with antibodies to Nnat, NAK, IB-, phospho-p65, p65, and -actin. D: Time course of IL-6 mRNA expression after Ad-Nnat infection of
endothelial cells (n  3). IL-6 mRNA expression levels were normalized to GAPDH. ***P < 0.001, **P < 0.01, *P < 0.05. Data are a representative
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matory gene expression through stimulation of TNF-
release by the cell, leading to ligation of TNF- cell surface
receptors. Cells were ﬁrst infected with Ad-Nnat to deter-
mine whether Nnat expression would result in activation
of NF-B in the presence of exogenous TNF-. Treatment
of Ad-Empty–infected HAECs with TNF- decreased IB-
protein level (Fig. 3A). Treatment of Nnat-expressing
HAECs with TNF- further decreased IB- protein.
We then removed any cellular TNF- using a neutraliz-
ing antibody. This did not block the Nnat-mediated de-
crease in IB- protein (Fig. 3B), increase in ICAM-1
mRNA, or increase in ICAM-1 and VCAM-1 protein expres-
sion (Fig. 3B and C). Expression of VCAM-1 was increased
with antibody treatment; VCAM-1 shedding was decreased
by TNF- absence in the culture media (24).
IL-6 mRNA expression, another read-out for NF-B
activation, was increased by TNF-, and this was further
augmented by Ad-Nnat viral infection (Fig. 3D). TNF-
neutralizing antibody blocked the TNF- induced increase
in IL-6 gene expression but had no effect on Nnat induced
IL-6 gene expression. These data indicate that Nnat acti-
vates the NF-B transcription factor and induces inﬂam-
matory gene expression by a pathway that does not
require cell surface TNF- receptor activation.
Nnat expression in HAEC-activated kinases. As we
have shown above, Nnat expression increased NAK and
phospho-p65 and decreased IB- protein. To learn what
kinases were involved in the signal transduction from Nnat
to NAK or p65 phosphorylation, we looked at mitogen-
activated protein kinase (MAPK) activation and compared
it with that of TNF-. Nnat expression induced phosphor-
ylation of p38, JNK, and ERK kinase (Fig. 3E). TNF-
treatment of HAECs induced phosphorylation of p38 and
JNK kinase but decreased Nnat-induced ERK phosphory-
lation. Nnat expression in HAECs also induced Akt phos-
phorylation (Fig. 3F), suggesting a role in activation of
phosphatidylinositol 3-kinase (PI 3-kinase).
Nnat induced signal transduction in endothelial cells.
To test whether Nnat-induced kinase phosphorylation was
involved in activation of NF-B, we treated Ad-Nnat–
infected endothelial cells with p38 (SB202190), JNK1,2,3
(SP600125), ERK1/2 kinase (U0126), PI 3-kinase (LY294002
and wortmannin), or IB kinase (IKK) (IKK-VII) inhibitors
(Fig. 4). SB202190, LY294002, wortmannin, and IKKVII
blocked the Nnat-induced IB- degradation and increase
in VCAM-1 protein. U0126 had the opposite effect; it
further increased VCAM-1 expression. SP600125 deceased
VCAM-1 protein expression without affecting IB- pro-
tein levels. LY294002 and wortmannin partially decreased
phosphorylation of p65 subunit. SB202190, SP600125, and
IKK-VII had no effect. Both LY294002 and SB202190
blocked (95%) the increase in IL-6 and SELE gene
expression in Ad-Nnat–infected endothelial cells (Fig. 4B
and C). U0126 had the opposite effect and increased IL-6
and SELE expression. SP600125 inhibitor only partially
(40%) blocked the Nnat-mediated increase in IL-6 but not
SELE expression. U0126 inhibited ERK phosphorylation
and increased p-JNK and p-AKT. SB202190 decreased AKT
and increased ERK phosphorylation. SP600125 decreased
JNK and p38 phosphorylation without having an effect on
others. This inhibitor is able to inhibit kinases upstream of
p38 and JNK. We could speculate that partial inhibition of
IL-6 but not SELE expression by this compound is a result
of blocking kinase upstream from p38 but not JNK itself.
LY294002 and wortmannin blocked Nnat-induced phos-
phorylation of NAK, p38, and JNK, suggesting that these
kinases are downstream from PI 3-kinase. IKK-VII treat-
ment blocked IB- degradation and did not effect p65
phosphorylation. On the other hand, IKK-VII inhibited
phosphorylation of all three MAPKs. As summarized in
Fig. 4D, Nnat effects on NF-B appear to be mediated via
PI 3-kinase and p38 and inhibited by ERK1/2.
Adenovirus-induced expression of Nnat in mouse
carotid arteries. To test whether Nnat can induce adhe-
sion molecule expression in endothelium in vivo, Ad-Nnat
or Ad-GFP was injected into carotid arteries of C57BL/6J
wild-type mice. Mouse arteries were harvested 2 days after
infection, and arterial sections were processed for deter-
mination of immunoreactive Nnat and VCAM-1. Ad-Nnat
increased the intensity of staining for the Nnat protein in
the endothelium approximately fourfold. Staining for
VCAM-1 increased by ninefold compared with staining of
arteries that had been infected with Ad-GFP (Fig. 5). These
data demonstrate that expression of Nnat in endothelium
induces endothelial expression of adhesion molecules in
vivo.
DISCUSSION
In the present study, using Affymetrix arrays, we found that
Nnat, a gene with unknown vascular functions, was upregu-
lated in both db/db and high-fat diet–fed mouse aortas.
Diabetes-associated changes in gene expression were quite
different between the two mouse models. Although insulin
TABLE 3
Genes differentially expressed in HAECs after transduction of HAECs with Ad-Nnat
Gene symbol Gene name Fold change P value
Cytokine and chemokine
IL-6 Interleukin 6 (interferon, 2) 29.4 	0.0001
IL-1 Interleukin 1 12 	0.0001
TNF Tumor necrosis factor 3.7 	0.05
Endothelial cell
adhesion molecules
and growth factors
MCP-1 Chemokine (C-C motif) ligand 2 6.1 	0.0001
SELE Selectin E 221 	0.001
VCAM-1 Vascular cell adhesion molecule 1 13 	0.0001
ICAM-1 Intercellular adhesion molecule 1 (CD54) 136 	0.001
Data presented are representative of three to six experiments. Fold change in gene expression is determined as difference in mRNA levels
for the gene of interest in Ad-Nnat– versus Ad-Empty–transduced HAECs. P values are determined using t test. n  4.
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mice, the db/db mouse has higher glucose levels. The degree
of metabolic abnormalities, the duration of diabetes (longer
in db/db), and the effect of the high-fat diet may be respon-
sible for the differences in gene expression across the two
diabetic models. Some gene expression changes found only
in db/db aortas are known to be associated with obesity or
diabetes. Angiopoietin-like protein 4 (ANGPTL4), which is
increased in the db/db aorta, inhibits lipoprotein lipase activ-
ity in vitro (25). ANGPTL4 also markedly inhibits the prolif-
eration, chemotaxis, and tubule formation of endothelial
cells (26). Two genes, other than leptin and Nnat, were
increased in both models of obesity and insulin resistance:
lectin, galactose binding, soluble 3, galectin-3 (LGALS3) and
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receptor that interacts with advanced glycation end products
(27). Npr3 encodes for a receptor for natriuretic peptides,
which are important in the maintenance of blood pressure
and extracellular ﬂuid volume (28). Another gene differen-
tially expressed in this model is transthyretin. Blood levels of
transthyretin are increased in serum of humans with type 2
diabetes (29).
Immunohistochemical staining revealed that Nnat was
expressed on the vascular endothelium. The function of
Nnat in vascular tissue is unknown. Previous studies
identiﬁed Nnat mRNA in the developing rat brain (30).
Nnat is an imprinted gene (31) and is expressed in
neonatal mouse brain, eye, bladder, colon, and lung;
mouse and human pituitary (32); and mouse pancreatic
-cell lines (33). Nnat expression in pancreas appears to
be regulated by the 2 transcription factor, also known as
NeuroD1. Knockdown of Nnat with small interfering RNA
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ulated insulin secretion (34).
It is not clear why Nnat expression was increased in
endothelial cells of obese and diabetic mice. Nnat is an
imprinted gene because its expression should be increased
by hypomethylation. Recent studies by several groups
found changes in concentrations of S-adenosylmethionine
(SAM) and S-adenosylhomocysteine (SAH) associated
with diabetes in human subjects and in animal models
(35,36). SAM is a universal donor of methyl groups.
Increased intracellular SAH levels are associated with
DNA hypomethylation in human umbilical vein endothelial
cells (37). Patients with vascular disease had signiﬁcantly
higher plasma SAH concentrations and signiﬁcantly lower
plasma SAM-to-SAH ratios and genomic DNA methylation
(38). Glycine N-methyltransferase (GNMT) is the enzyme
that converts SAM to SAH. We found a dramatic increase
in GNMT in aortas of db/db versus control mice (supple-
mentary Table 2) and speculated that the elevated levels of
this enzyme increased SAH levels and caused DNA hypom-
ethylation and greater Nnat expression. We found that
treatment of HAECs with DNA methyl transferase inhibi-
tor ADC increased Nnat transcript expression. ADC also
induced Nnat expression in HepG2 cells (39). It is inter-
esting to note that the leptin gene, which was also dramat-
ically increased in aortas, is regulated by promoter
methylation (40) and could also have been induced by
hypomethylation.
To investigate the function of Nnat in endothelial cells,
Nnat was expressed in HAECs using adenovirus mediated
gene transfer. Nnat expression induced a gene expression
pattern characteristic of endothelial cell activation with
increased inﬂammatory cytokines (TNF-, IL-1, and IL-
6), endothelial cell adhesion molecules (ICAM-1, VCAM-1,
and SELE), and chemokine (MCP-1) expression. Nnat
expression also induced VCAM-1 expression in the mouse
carotid artery. ICAM-1 expression was variable and did not
show a statistically signiﬁcant increase (data not shown).
It is possible that the increased Nnat in the arteries of the
diabetic mice increased inﬂammatory responses under
certain conditions.
Cell adhesion molecule and inﬂammatory cytokine gene
expression is regulated by NF-B. Expression of Nnat in
HAECs increased expression of NAK, decreased IB-
protein, and increased phosphorylation of the p65 subunit,
consistent with the activation of the NF-B transcription
complex. TNF- treatment of endothelial cells activates
JNK1/2 and p38 MAPK (41–43). In our study, TNF-
increased JNK1/2 and p38 and inhibited Nnat-induced
ERK1/2 phosphorylation. To understand whether Nnat
overexpression directly induced degradation of IB- or
increased TNF- triggered activation of other NF-B–
regulated genes, HAECs were transduced with Ad-Nnat
and incubated in medium containing TNF- antibody.
TNF- antibody did not block Nnat-induced activation of
gene expression. Therefore, Nnat effects do not appear to
involve extracellular TNF- interaction with cell surface
receptors.
We attempted to deﬁne the pathway whereby Nnat
induced inﬂammatory gene expression. We showed that
Nnat expression in HAECs induced phosphorylation of
p38, JNK, ERK, and Akt. Increased Akt suggested involve-
ment of PI 3-kinase in signal transduction from Nnat to
NF-B. PI 3-kinase inhibitors blocked Nnat-induced acti-
vation of IL-6 and SELE gene and VCAM-1 protein expres-
sion. SB202190, an inhibitor of p38 kinase, also blocked
Nnat-induced expression of IL-6 and SELE genes. Shed-
ding of VCAM-1 protein from cell membrane is regulated
by p38 kinase (24); therefore, the seemingly paradoxical
increase in VCAM-1 protein by SB202190 might be second-
ary to blocked shedding of this protein from the cell
surface. As expected, VCAM-1 expression was blocked by
an IKK inhibitor. Inhibition of JNK had no effect on SELE
but decreased IL-6 mRNA and VCAM-1 protein expression.
NF-B signaling can be inhibited at several levels,
including phosphorylation of I B- and p65. Nnat-induced
decrease in IB- protein level was reversed by IKK, p38,
and PI 3-kinase inhibitors. Blocking IKK or p38 had no
effect on phosphorylation of p65 subunit, whereas JNK1/2
and PI 3-kinase inhibitors decreased P-p65. Even though
Nnat increased JNK phosphorylation, the role of this
kinase in signal transduction from Nnat to NF-Bi sn o t
clear. Partial inhibition of gene expression by SP600125
could have resulted from decrease in p65 phosphorylation.
It is also possible that JNK activates other transcription
factors that work in concert with NF-B.
In contrast, inhibition of ERK kinase augmented Nnat-
induced activation of NF-B–regulated gene (IL-6 and
SELE) and protein (VCAM-1) expression. Several investi-
gators found inhibitory effects of ERK on NF-B transcrip-
tion factor–regulated gene expression; ERK inhibits IKK
activity (44), p65 subunit phosphorylation (45), and TATA
binding protein phosphorylation (46).
In summary, using a gene discovery approach, we
identiﬁed Nnat as a gene upregulated in the aortas of two
mouse models of obesity and type 2 diabetes, db/db and
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FIG. 5. Adenovirus-mediated expression of Nnat in mouse carotid
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aortic endothelium. Overexpression of Nnat in HAECs or
in mouse carotid artery increased endothelial cell adhe-
sion molecule expression. This effect of Nnat was medi-
ated through PI 3-kinase/p38–dependent activation of
NF-B. Nnat is an imprinted gene, and its expression in
diabetes might reﬂect alterations in the methylation status
of endothelial cells. We conclude that Nnat is a candidate
molecule involved in inﬂammatory pathways associated
with obesity and insulin resistance. Experiments to alter
Nnat gene expression in genetically modiﬁed mice are
underway to assess whether Nnat expression will promote
endothelial dysfunction and/or accelerate the develop-
ment of atherosclerosis.
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